Send a Tweet
Most Popular Choices
Share on Facebook 11 Share on Twitter 1 Printer Friendly Page More Sharing
Sci Tech   

Hydroxychloroquine Treatments Increased Coronavirus Survival Rate, Study Says

Quicklink Submitted By   16 comments
Author 500873
Follow Me on Twitter     Message David William Pear
Become a Fan
  (58 fans)

Main Stream Media Reports Study shows hydroxychloroquine and zinc treatments increased coronavirus survival rate by almost three times

Hydroxychloroquine molecule
Hydroxychloroquine molecule
(Image by ChiralJon)
  Details   DMCA

The observational study, published by medRxiv, found that antimalarial drug hydroxychloroquine, along with zinc, could increase the coronavirus survival rate by as much as nearly 200% if distributed at higher doses to ventilated patients with a severe version of the illness.

“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the study’s conclusion states.

The study adds:

Read the rest of the story HERE:

At news.yahoo.com
Must Read 3   Valuable 3   News 1  
Rate It | View Ratings

David William Pear Social Media Pages: Facebook Page       Twitter Page       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

David is a columnist writing on foreign affairs, economic, and political and social issues. He is an honorary Associate Editor of The Greanville Post, and a former Senior Editor of OpEdNews.com. His articles have been published by OpEdNews, The (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: